These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5491708)

  • 21. [Antibiotic therapy of infections caused by Proteus and Pseudomonas pyocyanea].
    Chernomordik AB
    Klin Med (Mosk); 1972 Nov; 50(11):106-9. PubMed ID: 4666690
    [No Abstract]   [Full Text] [Related]  

  • 22. The treatment of bacterial infections in the newborn infant.
    Dashefsky B; Klein JO
    Clin Perinatol; 1981 Oct; 8(3):559-77. PubMed ID: 7030577
    [No Abstract]   [Full Text] [Related]  

  • 23. Urinary tract infection and drug-resistant bacteria in different patient populations.
    Nitzan Y; Maayan M; Wajsman C; Drucker M
    Isr J Med Sci; 1983 Dec; 19(12):1039-45. PubMed ID: 6363352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chlorhexidine as the probable cause of an increase in Proteus rettgeri infections of the urinary tract.
    LUBSEN N; BOISSEVAIN W; FASS H
    Lancet; 1961 Apr; 1(7183):921-2. PubMed ID: 13763946
    [No Abstract]   [Full Text] [Related]  

  • 25. Beta-aminoketones as anti-infective agents.
    Gordon PN; Johnston JD; English AR
    Antimicrob Agents Chemother (Bethesda); 1965; 5():165-7. PubMed ID: 5883421
    [No Abstract]   [Full Text] [Related]  

  • 26. Carbapenemase producing Proteus: any therapeutic suggestions?
    Rai S; Niranjan DK; Singh NP; Kaur IR
    Indian J Med Microbiol; 2013; 31(2):200-1. PubMed ID: 23867685
    [No Abstract]   [Full Text] [Related]  

  • 27. [On postoperative urinary tract infections with special regard to diagnosis].
    Hirsch HA
    Gynaecologia; 1966; 161(4):327-38. PubMed ID: 5958749
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of 'resistant' otorrhea with acetic acid.
    Kothari A
    Laryngoscope; 1969 Mar; 79(3):494-8. PubMed ID: 5776741
    [No Abstract]   [Full Text] [Related]  

  • 29. [Proteus septicemias. Apropos of 4 cases].
    Leniaud P; Theobald X; Kankolongo T; Cornen L
    Med Trop (Mars); 1984; 44(2):137-42. PubMed ID: 6384721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Amikacin in the treatment of hospital infections of the urinary tract caused by gram-negative bacilli resistant to gentamicin. Microbiological and clinical aspects].
    Romoli E; Di Leonardo F; Giordano G; De Felice M; Cerquetti F; Vonmoos A
    Minerva Urol; 1981; 33(2):85-90. PubMed ID: 7322100
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use of benzylpenicillin in the treatment of Proteus infections].
    Fomina IP; Sorokina MI; Kuznetsova SM; Lobuseva AN; Navashin SM
    Antibiotiki; 1971 May; 16(5):450-4. PubMed ID: 5210806
    [No Abstract]   [Full Text] [Related]  

  • 32. [Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection].
    Pape L; Gunzer F; Ziesing S; Pape A; Offner G; Ehrich JH
    Klin Padiatr; 2004; 216(2):83-6. PubMed ID: 15106080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis.
    Saito R; Sato K; Kumita W; Inami N; Nishiyama H; Okamura N; Moriya K; Koike K
    J Antimicrob Chemother; 2006 Sep; 58(3):673-7. PubMed ID: 16870650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Superinfection induced by antibiotics in familial benign chronic pemphigus.
    Leyden JJ; Marples RR
    Acta Derm Venereol; 1973; 53(1):61-4. PubMed ID: 4120810
    [No Abstract]   [Full Text] [Related]  

  • 35. Antimicrobial agent resistance in bacterial isolates from patients with diarrhea and urinary tract infection in the Sudan.
    Ahmed AA; Osman H; Mansour AM; Musa HA; Ahmed AB; Karrar Z; Hassan HS
    Am J Trop Med Hyg; 2000; 63(5-6):259-63. PubMed ID: 11421374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ["Antibiotic hierarchy" oriented antibacterial chemotherapy in urinary tract infections].
    Walther H; Meyer FP; Kiessig R; Müller GW
    Z Urol Nephrol; 1982 Dec; 75(12):879-84. PubMed ID: 7164612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Frequency of isolation and antibiotic sensitivity of strains of coli bacilli from urinary tract infections isolated in private laboratories].
    Bourlioux P; Bourlioux N; Bournaud M
    Pathol Biol (Paris); 1983 Jun; 31(6):536-9. PubMed ID: 6348665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary tract infection in children: incidence of vesicoureteral reflux, imaging studies, and antimicrobial resistance among E. coli.
    Cheng CH; Chiu CH
    Acta Paediatr Taiwan; 2004; 45(6):313-4. PubMed ID: 15868844
    [No Abstract]   [Full Text] [Related]  

  • 39. [Urinary tract infections in patients with catheterization of the bladder].
    Gatta E
    Prof Inferm; 1997; 50(3):25-8. PubMed ID: 9653311
    [No Abstract]   [Full Text] [Related]  

  • 40. Transferable drug resistance (R-factor) among the enterobacteriaceae in urinary tract infections: a study at an urban hospital in Bangladesh.
    Chowdhury MA; Rahman KM; Miah MR; Haq JA
    J Trop Med Hyg; 1994 Jun; 97(3):161-6. PubMed ID: 8007056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.